Natera licenses OptraHEALTH’s patented conversational AI technology for patient communications
San Jose, CA, October 20, 2021 : Natera, the leading clinical genetics company licenses OptraHEALTH's, patented conversational AI technology for their initiatives related to patients and physician communications. OptraHEALTH’s flagship product HealthFAX™.AI is empowered by this patented technology to enhance patient education, experience and ultimately care for patients.
“Our advanced and patented AI technology coupled with Natera’s world-class clinical genetics testing solutions will empower Natera for their patient engagement related initiatives This endorses the power of our IP in the Healthcare segment”, said Dr Gauri Naik, Co-Founder & CEO, OptraHEALTH, Inc.





